Pharmaceutical drug research company Pharmaceutical Product Development, Inc. (NASDAQ:PPDI) recently announced that it has entered into an agreement to be acquired by privately held The Carlyle Group and Hellman & Friedman for $3.9 billion in cash.
PPD shareholders have been offered a cash consideration of $33.25 per share, a premium of 29.6% over the stock’s closing price on September 30. The transaction has won unanimous approval of PPD’s board while shareholder approval is awaited. The … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards